Company intelligence / Profile preview

Ampersand Biosciences

Lake Clear, New York, United Statesampersandbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ampersand Biosciences develops and manufactures highly validated multiplex immunoassays for the Luminex platform as well as proteins and antibodies. The company offers custom assay development services and sample testing using GLP protocols. Their products support drug discovery by enabling accurate biomarker measurement in preclinical models. They do not have a clinical pipeline or direct clinical results.

Therapeutic areas: Other
Modalities: Antibody (monoclonal and polyclonal)Recombinant proteinImmunoassay kit (Luminex multiplex, ELISA)Protein (as reagents)
Industry: Protein Biomarker Diagnostics

Partnerships

Bioz Inc. (AI-powered citation display widgets partnership)

Beyond the preview

Go deeper on Ampersand Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ampersand Biosciences.

Explore the full profile